About the bill
- Full Title
To provide incentives for investment in research and development for new medicines, to enhance access to new medicines, and for other purposes.
- Summary (CRS)
1/26/2005--Introduced.Medical Innovation Prize Act of 2005 - Prohibits any person from having the right to exclusively manufacture, distribute, sell, or use a drug, a biological product, or a manufacturing process ...
Read more >
The bill’s title was written by its sponsor.
Jan 26, 2005
This is the first step in the legislative process.
Read Text »
Oct 19, 2007
Reintroduced Bill —
This activity took place on a related bill, S. 2210 (110th).
This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 417”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
- Related Bills
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
S. 2210 (110th)
was a re-introduction of this bill in a later Congress.
Referred to Committee
Last Action: Oct 19, 2007
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 417 — 109th Congress: Medical Innovation Prize Act of 2005. Retrieved from https://www.govtrack.us/congress/bills/109/hr417
“H.R. 417 — 109th Congress: Medical Innovation Prize Act of 2005.” www.GovTrack.us. 2005. October 5, 2015 <https://www.govtrack.us/congress/bills/109/hr417>
|title=H.R. 417 (109th)
|accessdate=October 5, 2015
|author=109th Congress (2005)
|date=January 26, 2005
|quote=Medical Innovation Prize Act of 2005